These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9484755)

  • 1. Diabetes mellitus after renal transplantation: as deleterious as non-transplant-associated diabetes?
    Miles AM; Sumrani N; Horowitz R; Homel P; Maursky V; Markell MS; Distant DA; Hong JH; Sommer BG; Friedman EA
    Transplantation; 1998 Feb; 65(3):380-4. PubMed ID: 9484755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M; Safranow K; Dziewanowski K; Debska-Slizień A; Głyda M; Gołembiewska E; Jankowska M; Nowosiad M; Rutkowski B; Ciechanowski K
    Ann Acad Med Stetin; 2008; 54(1):41-8. PubMed ID: 19127808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM; Bakr MA; Metwally AH; Wahab AM
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autosomal-dominant polycystic kidney disease as a risk factor for diabetes mellitus following renal transplantation.
    de Mattos AM; Olyaei AJ; Prather JC; Golconda MS; Barry JM; Norman DJ
    Kidney Int; 2005 Feb; 67(2):714-20. PubMed ID: 15673321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year.
    Ciancio G; Burke GW; Gaynor JJ; Mattiazzi A; Roth D; Kupin W; Nicolas M; Ruiz P; Rosen A; Miller J
    Transplantation; 2004 Jan; 77(2):252-8. PubMed ID: 14742990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney transplantation in type 2 diabetic patients: a comparison with matched non-diabetic subjects.
    Boucek P; Saudek F; Pokorna E; Vitko S; Adamec M; Koznarova R; Lanska V
    Nephrol Dial Transplant; 2002 Sep; 17(9):1678-83. PubMed ID: 12198223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney transplantation in patients with type 1 diabetes mellitus: long-term prognosis for patients and grafts.
    Kim H; Cheigh JS
    Korean J Intern Med; 2001 Jun; 16(2):98-104. PubMed ID: 11590909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttransplant diabetes mellitus: Impact of good blood glucose regulation on renal transplant recipient outcome.
    Sezer S; Akgul A; Altunoglu A; Arat Z; Ozdemir FN; Haberal M
    Transplant Proc; 2006 Mar; 38(2):533-6. PubMed ID: 16549167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal impairment and diabetes mellitus after liver transplant.
    Sutedja DS; Wai CT; Teoh KF; Lee HL; DaCosta M; Lee M; Kaur M; Lee YM; Lee KH; Mak K; Quak SH; Isaac J; Lim SG; Prabhakaran K
    Transplant Proc; 2004 Oct; 36(8):2324-7. PubMed ID: 15561238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors and outcomes associated with posttransplant diabetes mellitus in kidney transplant recipients.
    Siraj ES; Abacan C; Chinnappa P; Wojtowicz J; Braun W
    Transplant Proc; 2010 Jun; 42(5):1685-9. PubMed ID: 20620501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up.
    Shaffer D; Simpson MA; Madras PN; Sahyoun AI; Conway PA; Davis CP; Monaco AP
    Arch Surg; 1995 Mar; 130(3):283-7; discussion 287-8. PubMed ID: 7887795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular morbidity and mortality in patients with diabetes mellitus type I after kidney transplantation: a case-control study.
    Lufft V; Dannenberg B; Schlitt HJ; Pichlmayr R; Brunkhorst R
    Clin Nephrol; 2004 Apr; 61(4):238-45. PubMed ID: 15125029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors of long-term graft loss in renal transplant recipients with chronic allograft dysfunction.
    Khalkhali HR; Ghafari A; Hajizadeh E; Kazemnejad A
    Exp Clin Transplant; 2010 Dec; 8(4):277-82. PubMed ID: 21143092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Frequency of T-cell mediated rejection in new-onset diabetes after kidney transplantation].
    Borda B; Szederkényi E; Lengyel C; Várkonyi T; Hódi Z; Kemény É; Szabó V; Lázár G
    Orv Hetil; 2015 May; 156(19):785-9. PubMed ID: 26039918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic kidneys can safely expand the donor pool.
    Becker YT; Leverson GE; D'Alessandro AM; Sollinger HW; Becker BN
    Transplantation; 2002 Jul; 74(1):141-5. PubMed ID: 12134115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High impact of rejection therapy on the incidence of post-transplant diabetes mellitus after kidney transplantation.
    Schweer T; Gwinner W; Scheffner I; Schwarz A; Haller H; Blume C
    Clin Transplant; 2014 Apr; 28(4):512-9. PubMed ID: 24649873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants?
    Choi JY; Kwon OJ
    Transplant Proc; 2013 Oct; 45(8):2892-8. PubMed ID: 24156999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
    Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.